Simultaneously, the rising global prevalence of obesity, diabetes and associated conditions has fueled growing demand for effective therapeutic solutions
Your plan may change based on your response, the underlying diagnosis, and whether youre combining IGF with other treatments
Although this is less common when Semaglutide GLP-1 is used alone as a monotherapy, the associated risk escalates in conjunction with other diabetic drugs, particularly insulin and sulfonylureas
Disclaimer: This is not a large study and does not include many patients
Hypoglycemia (Low Blood Sugar) Because IGF-1 mimics insulin, it can cause increased glucose uptake into cells which, without adequate carb intake, may lead to symptoms of hypoglycemia (shakiness, fatigue, dizziness)
If you want the compound with the bigger current metabolic narrative, retatrutide clearly has more momentum